Home > Boards > US OTC > Delisted > Attis Industries Inc. (fka ATIS) (ATIS)

On Attis’ partners site on ihub I posted

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
oldrogue Member Profile
Followed By 1
Posts 458
Boards Moderated 0
Alias Born 03/15/12
160x600 placeholder
oldrogue   Friday, 04/09/21 12:08:40 PM
Re: None
Post # of 1437 
On Attis’ partners site on ihub I posted an SEC change in their rules. This change will more than likely force both Atis and Gers to file their quarterly financials? The post below comes from post # 67494 on UN.C site. Atis’ moderator should be familiar with it.

From Dark non-reporting to Pink Current

The upcoming implementation of amended SEC Rule 15c2-11 will require that all companies quoted on our markets must disclose current information on a continuous basis, effective September 28, 2021. Companies must follow the Guidelines to be designated “Current Information” or “Limited Information” to remain publicly quoted.

Impacted companies should provide the required disclosure to OTC Markets by June 30th. This will ensure that our Issuer Compliance Team has sufficient time to review and update market status for companies prior to the rule’s compliance date on September 28th. Securities that do not meet the Rule’s disclosure standard will have their public quotes removed from Pink as of the September deadline.

Companies will be processed for Current Information once all required documentation has been submitted:

• Financial Statements: Two most recent Annual reports and any subsequent Quarterly Report

• Disclosure Statement: Most recent Annual and any subsequent Quarterly Reports

• Attorney Letter covering all relevant information for non-audited companies

• The Company Profile has been verified through OTCIQ

Not quite as simple as just filing an 8K.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences